Literature DB >> 22985963

Synthesis and antiviral activity of 4,6-disubstituted pyrimido[4,5-b]indole ribonucleosides.

Michal Tichý1, Radek Pohl, Hao Ying Xu, Yen-Liang Chen, Fumiaki Yokokawa, Pei-Yong Shi, Michal Hocek.   

Abstract

A series of new pyrimido[4,5-b]indole ribonucleosides bearing phenyl or hetaryl group at position 4 has been prepared by selective Pd-catalyzed cross-coupling reactions of the corresponding protected 4,6-dichloropyrimido[4,5-b]indole ribonucleoside with (het)arylboronic acids or stannanes followed by deprotection. Further cross-couplings under harsher conditions and employing X-Phos ligand proceeded at the position 6 leading to 4,6-disubstituted pyrimido[4,5-b]indole ribonucleosides. Some of these compounds displayed antiviral activity against Dengue virus.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22985963     DOI: 10.1016/j.bmc.2012.08.021

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  6 in total

1.  A simple and facile synthesis of tricyclic-fused pyrimido[4,5-b]indol-2-amines.

Authors:  Wentao Gao; Dongfang Wang; Yang Li
Journal:  Mol Divers       Date:  2017-06-19       Impact factor: 2.943

2.  Design, synthesis, and structure-activity relationships of pyrimido[4,5-b]indole-4-amines as microtubule depolymerizing agents that are effective against multidrug resistant cells.

Authors:  Ravi Kumar Vyas Devambatla; Wei Li; Nilesh Zaware; Shruti Choudhary; Ernest Hamel; Susan L Mooberry; Aleem Gangjee
Journal:  Bioorg Med Chem Lett       Date:  2017-05-27       Impact factor: 2.823

3.  Discovery and Evaluation of Enantiopure 9H-pyrimido[4,5-b]indoles as Nanomolar GSK-3β Inhibitors with Improved Metabolic Stability.

Authors:  Stanislav Andreev; Tatu Pantsar; Ahmed El-Gokha; Francesco Ansideri; Mark Kudolo; Débora Bublitz Anton; Giulia Sita; Jenny Romasco; Christian Geibel; Michael Lämmerhofer; Márcia Ines Goettert; Andrea Tarozzi; Stefan A Laufer; Pierre Koch
Journal:  Int J Mol Sci       Date:  2020-10-22       Impact factor: 5.923

Review 4.  Pyrrolo[2,3-d]pyrimidine (7-deazapurine) as a privileged scaffold in design of antitumor and antiviral nucleosides.

Authors:  Pavla Perlíková; Michal Hocek
Journal:  Med Res Rev       Date:  2017-08-23       Impact factor: 12.944

5.  Tuning Cross-Coupling Approaches to C3 Modification of 3-Deazapurines.

Authors:  Łukasz J Weseliński; Vagarshak Begoyan; Alexis Ferrier; Marina Tanasova
Journal:  ACS Omega       Date:  2017-10-20

6.  Sugar modified pyrimido[4,5-b]indole nucleosides: synthesis and antiviral activity.

Authors:  Juraj Konč; Michal Tichý; Radek Pohl; Jan Hodek; Petr Džubák; Marián Hajdúch; Michal Hocek
Journal:  Medchemcomm       Date:  2017-08-25       Impact factor: 3.597

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.